<p>Cell fraction of the flow cytometric cell cycle analysis is presented in % of total cell population in a) G<sub>1</sub>/G<sub>0</sub>-phase, b) G<sub>2</sub>/M-phase and c) S-phase in A549 and A549<sup>r</sup>CDDP<sup>2000</sup> cells as untreated controls or after treatment with 11 μM or 34 μM cisplatin presented as mean ± SEM.</p
<p>(A) 0.1% DMSO treatment for 48 h was used as a vehicle control. The percentage of IC<sub>50</sub>...
Distribution of A2780 and A2780cis cells in G1, S, and G2/M phases of the cell cycle after 5 mM NaBu...
<p>(A) A549 cells were treated with 50 μg/mL PGL for 24, 48, and 72 h and were then harvested to det...
<p>Exp: number of experiments performed. Treat: treatment. Temp: temperature. Con: untreated control...
<p>Parent and Cisplatin resistant NSCLC cells were treated with cisplatin for 24 h. Cell cycle distr...
<p>The cell cycle distribution was detected by flowcytometry. (A,B)The proportion of G0/G1 phase cel...
a<p>These data indicate the percentage of cells in G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>...
<p>Right panel-The percentage of cells at different stages in both MCF7 and U87 cells with and witho...
<p>The percentage of α-tomatine-treated cells at A) Sub G<sub>1</sub>, B) G<sub>0</sub>/G<sub>1</sub...
<p>(A). Cell cycle profiles showing the distribution of cells in the different phases of the cell cy...
MEC-1 cells (3 ×105 cells/mL) were treated with the vehicle control (0.1% DMSO) or 1 µM MRT68921 for...
<p>A, B and C, Flow cytometric analysis of the cell cycle distribution of SW620 cells transfected wi...
<p>Representative cell cycle graphs of BM-MSCs (A) and CESCs (B) were showed. The percentage of cell...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...
<p>Sub-G1, G1, S, and G2/M phases of PRME (300 µg/ml) treated MCF-7 cells at (A) 0 hour, (B) 6 hours...
<p>(A) 0.1% DMSO treatment for 48 h was used as a vehicle control. The percentage of IC<sub>50</sub>...
Distribution of A2780 and A2780cis cells in G1, S, and G2/M phases of the cell cycle after 5 mM NaBu...
<p>(A) A549 cells were treated with 50 μg/mL PGL for 24, 48, and 72 h and were then harvested to det...
<p>Exp: number of experiments performed. Treat: treatment. Temp: temperature. Con: untreated control...
<p>Parent and Cisplatin resistant NSCLC cells were treated with cisplatin for 24 h. Cell cycle distr...
<p>The cell cycle distribution was detected by flowcytometry. (A,B)The proportion of G0/G1 phase cel...
a<p>These data indicate the percentage of cells in G<sub>0</sub>/G<sub>1</sub>, S, and G<sub>2</sub>...
<p>Right panel-The percentage of cells at different stages in both MCF7 and U87 cells with and witho...
<p>The percentage of α-tomatine-treated cells at A) Sub G<sub>1</sub>, B) G<sub>0</sub>/G<sub>1</sub...
<p>(A). Cell cycle profiles showing the distribution of cells in the different phases of the cell cy...
MEC-1 cells (3 ×105 cells/mL) were treated with the vehicle control (0.1% DMSO) or 1 µM MRT68921 for...
<p>A, B and C, Flow cytometric analysis of the cell cycle distribution of SW620 cells transfected wi...
<p>Representative cell cycle graphs of BM-MSCs (A) and CESCs (B) were showed. The percentage of cell...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...
<p>Sub-G1, G1, S, and G2/M phases of PRME (300 µg/ml) treated MCF-7 cells at (A) 0 hour, (B) 6 hours...
<p>(A) 0.1% DMSO treatment for 48 h was used as a vehicle control. The percentage of IC<sub>50</sub>...
Distribution of A2780 and A2780cis cells in G1, S, and G2/M phases of the cell cycle after 5 mM NaBu...
<p>(A) A549 cells were treated with 50 μg/mL PGL for 24, 48, and 72 h and were then harvested to det...